Table 1.
Sex, age and 25-OH-D3 serum levels of the test persons included in this study
| ID | Sex | Age (years) | Before substitution | After substitution | ||
|---|---|---|---|---|---|---|
| Deficiency/insufficiency (ng/ml) | Lower normal range (ng/ml) | Mid normal range (ng/ml) | High normal range (ng/ml) | |||
| 1 | m | 50 | – | 35.1a | 70.1 | 123.0 |
| 4 | f | 46 | – | 32.2a | 71.5 | 110.0 |
| 50 | m | 33 | 11.4 | 34.6 | 57.2 | 103.0 |
| 55 | m | 32 | 14.3 | 33.3 | 67.4 | 93.6 |
| 56 | m | 59 | 4.0 | 32.5 | 71.7 | – |
| 57 | f | 30 | – | 31.5a | 61.2 | 90.5 |
| 61 | f | 40 | – | 36.9a | 68.4 | 102 |
| 66 | f | 64 | 8.7 | 27.7 | 68.2 | 86.4 |
| 67 | m | 70 | 9.0 | 33.8 | 65.5 | 89.6 |
| 70 | m | 78 | 5.9 | 24.5 | 64.3 | 110.0 |
| 71 | f | 71 | 23 | 33.9 | 68.2 | 115.0 |
| 72 | m | 57 | 15.7 | 45.8 | 62.6 | 89.0 |
| 73 | f | 78 | 4.6 | 28.1 | 68.8 | 83.4 |
| 74 | m | 79 | 6.1 | 31.3 | 72.8 | 94.9 |
| 75 | f | 79 | 9.7 | 31.7 | 68.5 | 72.1 |
| 87 | m | 56 | – | 30.5a | 69.4 | 81.0 |
| 91 | f | 83 | 9.8 | 27.6 | 63.6 | 88.8 |
| 92 | m | 86 | 10.3 | 27.3 | 58.2 | 74.4 |
| 93 | f | 80 | 5.9 | 25.8 | 63.7 | – |
| 99 | f | 42 | 8.8 | 38.8 | 61.5 | 86.8 |
| Mean | f and m | 60.7 | 9.8 | 32.1 | 66.1 | 94.1 |
| SD | 18.3 | 4.9 | 4.9 | 4.4 | 13.9 | |
| Mean | f | 61.3 | 10.1 | 31.4 | 66.4 | 92.8 |
| SD | 18.9 | 6.0 | 4.2 | 3.5 | 13.6 | |
| Mean | m | 60 | 9.6 | 32.9 | 65.9 | 95.4 |
| SD | 17.6 | 4.2 | 5.6 | 5.4 | 14.8 | |
f Female, m male
aDue to the season or self-initiated prophylactic substitution these test persons did not receive Dekristol to reach the lower normal range